Abstract: The present disclosure relates to a pyrotechnic object, in particular an irritation body, irritation projectile or ammunition, comprising an ignition device, comprising a delay chamber extending along a delay path, in which chamber a delay charge is accommodated, and comprising at least one and preferably a plurality of effect chambers in which or in each of which an effect charge to be ignited is accommodated, wherein the delay chamber is transversely connected to a respective effect chamber via a respective over-ignition opening which branches off from the delay chamber and forms an over-ignition path, wherein in the case of a plurality of effect chambers the plurality of over-ignition openings are arranged successively downstream along the delay path in the order of the effect charges to be ignited.

Abstract: The present disclosure is concerned with the technical field of marking objects with optically readable codes and reading out (decoding) the codes. Subjects of the present disclosure are a method, a system and a computer program product for decoding optically readable codes introduced in surfaces of objects.

Abstract: The invention relates to a compound for use in a method of treatment or prevention of migraine and/or symptoms thereof. The compound is selected from beta-hydroxybutyric acid (?HB) or a pharmaceutically acceptable salt thereof, acetoacetate (AcAc) or a pharmaceutically acceptable salt thereof, a metabolic precursor of ?HB or AcAc 1,3-butanedio and a compound comprising an acetoacetyl- or 3-hydroxybutyrate moiety. The invention further relates to a pharmaceutical composition comprising ?HB, AcAc or a pharmaceutically acceptable salt thereof.

Abstract: A process for forming 2-hydroxypyridine-1-oxide or derivatives thereof, the process comprising inter alia providing a solution comprising at least one compound according to Formula (1) and recovering a compound according to Formula (2) Also related products, uses, methods and compositions.

Abstract: A water-soluble and/or water-swellable hybrid polymer comprising: (i) from 5 wt.-% to 95 wt.-% water-soluble and/or water-swellable polysaccharide polymer selected from the group consisting of xanthan gum, carrageenan, guar gum, chitosan, alginate and combinations thereof; (ii) from 5 wt.-% to 95 wt.-% synthetic polymer comprising up to 100 mol-% repeating units according to Formula (1a): wherein components (i) and (ii) are polymerized by radical precipitation polymerization in a polar solvent.

Abstract: This invention relates to water-soluble or water-swellable polymers, containing a) 25-35 mol. % of one or more recurrent structural units of formula (1), where R1 and R2 represent hydrogen, methyl or ethyl, A represents a linear or branched C1-C12-alkylene, and Q+ stands for NH4+, Li+, Na+, K+, ½ Ca++, ½ Mg++, ½ Zn++, ? Al+++, or organic ammonium ions of the formula [HNR5R6R7]+, b) 3 to 8 mol. % of one or more recurrent structural units of formula (2), where R1 represents hydrogen, methyl, or ethyl, X+ stands for H+, NH4+, Li+, Na+, K+, ½ Ca++, ½ Mg++, ½ Zn++, ? Al+++, or organic ammonium ions of the formula [HNR5R6R7]+, B is a linear or branched alkylene group with 1 to 6 carbon atoms, and n is a whole number between 0 and 5, and c) 57 to 72 mol. % of a (meth)acrylamide.

Abstract: A water-soluble and/or water-swellable hybrid polymer comprising: (i) from 5 wt.-% to 95 wt.-% water-soluble and/or water-swellable polysaccharide polymer; (ii) from 5 wt.-% to 95 wt.-% synthetic polymer comprising: (a) from 40 mol-% to 99 mol-% of repeating units according to Formula (1) (b) from 0.01 mol-% to 5 mol-% crosslinking or branching units, wherein the crosslinking or branching units result from the incorporation of a monomer comprising at least two olefinically unsaturated double bonds; (c) from 0.99 mol-% to 59.99 mol-% of repeating neutral structural units; wherein components (i) and (ii) are polymerized by radical precipitation polymerization in a polar solvent.

Abstract: The present invention relates to a polymer comprising: (a) from 90 mol-% to 99.9 mol-%, of repeating units according to Formula (1) wherein at least 10 wt.-% of the repeating units according to Formula (1) comprise from 28 wt.-% to 100 wt.-% bio-based carbon content, relative to the total mass of carbon in the repeating unit according to Formula (1), measured according to standard ASTM D6866-12, Method B; and (b) from 0.01 mol-% to 10 mol-% of crosslinking or branching units, wherein the crosslinking or branching units result from the incorporation of a monomer comprising at least two olefinically unsaturated double bonds.

Abstract: The present invention relates to the use of a polymer in a cosmetic, dermatological or pharmaceutical composition, wherein the polymer is crosslinked or non-crosslinked, characterized in that the polymer comprises at least 9.49 mol-% of repeating units (a) according to Formula (1) wherein at least 10 wt.-%, preferably at least 20 wt.-% of the repeating units according to Formula (1) comprise from 28 wt.-% to 100 wt.

Abstract: A water-soluble and/or water-swellable hybrid polymer comprising: (i) from 5 wt.-% to 95 wt.-% water-soluble and/or water-swellable polysaccharide polymer; (ii) from 5 wt.-% to 95 wt.-% synthetic polymer comprising: (a) from 90 mol-% to 99.9 mol-%, preferably 95 mol-% to 99.5 mol-% of repeating units according to Formula (1) (b) from 0.01 mol-% to 10 mol-%, preferably to 5 mol-%, more preferably to 3 mol-% of crosslinking or branching units, wherein the crosslinking or branching units result from the incorporation of a monomer comprising at least two olefinically unsaturated double bonds; wherein components (i) and (ii) are polymerized by radical precipitation polymerization in a polar solvent.

Abstract: The present invention relates to the use of a polymer in a cosmetic, dermatological or pharmaceutical composition, wherein the polymer is crosslinked or non-crosslinked, characterized in that the polymer comprises at least 9.49 mol-% of repeating units (a) according to Formula (1) wherein at least 10 wt.-%, preferably at least 20 wt.-% of the repeating units according to Formula (1) comprise from 28 wt.-% to 100 wt.

Abstract: A water-soluble and/or water-swellable hybrid polymer comprising: (i) from 5 wt.-% to 95 wt.-% water-soluble and/or water-swellable polysaccharide polymer; (ii) from 5 wt.-% to 95 wt.-% synthetic polymer comprising: (a) from 40 mol-% to 99.9 mol-% repeating units according to Formula (1) (b) from 0.01 mol-% to 5 mol-% crosslinking or branching units, wherein the crosslinking or branching units result from the incorporation of a monomer comprising at least two olefinically unsaturated double bonds; (c) from 0.01 mol-% to 88.51 mol-% of neutral structural units; (d) from 1.98 mol-% to 20 mol-% of anionic structural units, wherein the repeating anionic structural units result from the incorporation of a monomer comprising at least one carboxylate anion, and wherein the repeating anionic structural units are different from units (a); wherein components (i) and (ii) are polymerized by radical precipitation polymerization in a polar solvent.

Abstract: A tilt-decoupled steering device of a motorbike includes a handlebar bridge which receives a handlebar, a fork bridge which receives a fork leg, and a decoupling element connecting the handlebar bridge to the fork bridge. The handlebar bridge (11) is rotatable about a steering axis and is secured about a tilt axis orthogonal to the steering axis. The fork bridge is rotatable about the steering axis and about the tilt axis. The decoupling element is elastic and is designed to transfer a steering movement in a steering direction about the steering axis from the handlebar bridge to the fork bridge, and to compensate for a tilting movement in a tilting direction about the tilt axis of the fork bridge relative to the handlebar bridge via elastic deformation.

Abstract: A tilt-decoupled steering device of a motorbike includes a handlebar bridge for receiving a motorbike handlebar, a fork bridge for receiving a fork leg, and at least one decoupling device connecting the handlebar bridge to the fork bridge. The handlebar bridge is mounted such that it can rotate about a steering axis and is secured about a tilt axis orthogonal to the steering axis, and the fork bridge is mounted such that it can rotate about the steering axis and about the tilt axis. The decoupling device transfers a steering movement and a steering torque in a steering direction about the steering axis between the handlebar bridge and the fork bridge, and compensates for a tilting movement in a tilting direction about the tilt axis of the fork bridge relative to the handlebar bridge.

Abstract: An overhead stowage compartment of a passenger aircraft includes a carrier and a pivoting part being pivotable about a pivot axis and rotatable in a pivoting range at least between an open position and a closing position. A resetting device brings about a closing force in the direction of the closing position at a gripping point of the pivoting part. The closing force is greater than and opposed to the gravitational force, which is effective at the gripping point, by using the unloaded pivoting part. The stowage compartment has a holding device through the use of which the pivoting part can be held at the open position.

Abstract: The invention relates to a compound for use in a method of treatment or prevention of migraine and/or symptoms thereof. The compound is selected from beta-hydroxybutyric acid (?HB) or a pharmaceutically acceptable salt thereof, acetoacetate (AcAc) or a pharmaceutically acceptable salt thereof, a metabolic precursor of ?HB or AcAc 1,3-butanedio and a compound comprising an acetoacetyl- or 3-hydroxybutyrate moiety. The invention further relates to a pharmaceutical composition comprising ?HB, AcAc or a pharmaceutically acceptable salt thereof.

Abstract: The invention relates to a compound for use in a method of treatment or prevention of migraine and/or symptoms thereof. The compound is selected from beta-hydroxybutyric acid (?HB) or a pharmaceutically acceptable salt thereof, acetoacetate (AcAc) or a pharmaceutically acceptable salt thereof, a metabolic precursor of ?HB or AcAc 1,3-butanedio and a compound comprising an acetoacetyl- or 3-hydroxybutyrate moiety. The invention further relates to a pharmaceutical composition comprising ?HB, AcAc or a pharmaceutically acceptable salt thereof.

Abstract: The present invention relates to a compound according to Formula (3), wherein the compound comprises from 28 wt. % to 100 wt. % bio-based carbon content, relative to the total mass of carbon in the compound, measured according to standard ASTM D6866-12, Method B; and wherein X+is a proton. The present invention also relates to a polymer obtained by polymerising at least one of compound according to Formula (3), in addition to processes and uses related thereto.

Abstract: A process for forming 2-hydroxypyridine-1-oxide or derivatives thereof, the process comprising inter alia providing a solution comprising at least one compound according to Formula (1) and recovering a compound according to Formula (2) Also related products, uses, methods and compositions.

Abstract: A connector assembly for connecting medical lines (3, 4) to each other comprises a first connector (1) having an insertion shaft (12) to be inserted, along an insertion direction (I), into an insertion opening (22) of a second connector (2) for forming a fluid connection between the medical lines (3, 4), the insertion shaft (12) comprising a fluid channel (120) allowing fluid to flow in between the first connector (1) and the second connector (2). Herein, a cap element (14) is attachable to the first connector (1) for closing the fluid channel (120) towards the outside in a state in which the first connector (1) is not connected to the second connector (2), the first connector (1) having a first retention device (123) and the cap element (14) having a second retention device (143), the first retention device (123) and the second retention device (143) being configured to form a positive locking engagement in between the cap element (14) and the first connector (1) along the insertion direction (I).